These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 20549316

  • 1. Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells.
    Su X, Zhang L, Jin L, Ye J, Guan Z, Chen R.
    J Clin Immunol; 2010 Sep; 30(5):766-74. PubMed ID: 20549316
    [Abstract] [Full Text] [Related]

  • 2. Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells.
    Lu X, Zhu A, Cai X, Jia Z, Han W, Ma L, Zhou M, Qian K, Cen L, Chen B.
    Cancer Biol Ther; 2012 Jun; 13(8):623-9. PubMed ID: 22555808
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells.
    Erhardt M, Schmidt-Wolf IG, Sievers E, Frank S, Strehl J, von Lilienfeld-Toal M, Gorschlüter M.
    Arch Immunol Ther Exp (Warsz); 2006 Jun; 54(6):403-9. PubMed ID: 17122879
    [Abstract] [Full Text] [Related]

  • 6. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
    Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, Introna M.
    Blood; 2011 Sep 22; 118(12):3301-10. PubMed ID: 21821703
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].
    DU Z, Zhao XL, Gao YT, Wu CX, Wang YJ, Zhu ZY, Sun Q, Fang SC.
    Zhonghua Zhong Liu Za Zhi; 2008 Oct 22; 30(10):759-63. PubMed ID: 19173806
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines].
    Li SJ, Zhang LS, Chai Y, Zhang YF, Zhang YM, Zeng PY, Wu CY.
    Zhonghua Zhong Liu Za Zhi; 2007 Oct 22; 29(10):733-7. PubMed ID: 18396683
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
    Sugai S, Yoshikawa T, Iwama T, Tsuchiya N, Ueda N, Fujinami N, Shimomura M, Zhang R, Kaneko S, Uemura Y, Nakatsura T.
    Int J Oncol; 2016 May 22; 48(5):1794-804. PubMed ID: 26936487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.